Published on 18th February 2013
Shares in AIM-listed Sareum Holdings, the specialist cancer drug discovery business, fell sharply on Monday morning after the company unveiled its half yearly results alongside a research update.
URL: http://www.digitallook.com/dl/news/story/20702117/...